Your institution may have access to this item. Find your institution then sign in to continue.
Title
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
Authors
Aubert, R E; Herrera, V; Chen, W; Haffner, S M; Pendergrass, M
Abstract
The objectives of the study were to determine whether thiazolidinedione (TZD) use is associated with an increased risk of fracture in men and women with type 2 diabetes mellitus and to compare the effects of pioglitazone and rosiglitazone.